What is CPIX's market cap?

$66.52M, based on the Nov 4 close of $4.44.

Does Cumberland Pharmaceuticals pay a dividend?

Yes. The latest regular dividend was $1.5 per share (ex-date Aug 3), an annualised yield of 33.78%.

How much of CPIX is sold short?

336.0K shares, 3.9% of float, as of Oct 15, 2026.

What sector is CPIX in?

Healthcare, in the Pharmaceuticals industry.

NASDAQ · CPIXHealthcarePharmaceuticals

Cumberland Pharmaceuticals Inc (CPIX)

$4.44+3.02%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$4.44▲ 66.92% in range

Nov 4, 2025Low $1.90 · High $8.97Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Cumberland Pharmaceuticals closed at $4.44 on Nov 4, up 3.02%, 50.5% below its 52-week closing high. Volume of 449.7K shares was 3.45× its 20-day average (well above normal).

Split-adjusted performance: -37.8% over one month, +1.6% over six months, +60.9% over one year.

In the quarter ended Jun 30, 2026, revenue was $166.46K, down 56.3% from a year earlier, with a net margin of -2569.0%.

Short interest was 336.0K shares at the Oct 15 settlement, down 3.7% from the prior report (3.9% of float, 9.0 days to cover).

Market cap$66.5M15.0M shares

Revenue · quarter$166.5K−56.3% YoY

Diluted EPS$-0.29—

P/E · TTM—P/S 2.1×

Net margin-2,569.0%Gross 100.0%

Dividend yield33.78%$1.5 last paid

52-week range1.90 – 8.97−50.5% from high

Volume449.7K3.45× 20-day avg

Volatility · 60d162.7%Annualised

Short % of float3.9%9.0 days to cover

Net cash$3.9MCash $3.9M

Next earnings—Not scheduled

Split-adjusted performance

1W −8.8%1M −37.8%3M −42.2%6M +1.6%YTD +11.6%1Y +60.9%3Y +126.5%5Y +72.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum73

Revenue growth20

Net margin11

Value (low P/E)—

Size36

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short336.0K−3.7% vs prior

Days to cover9.0Settled Oct 15

% of float3.9%

Short vol. 10d41.5%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
CPIXCumberland Pharmaceuticals	$4.44	+3.02%	+1.6%	−56.3%	−2569.0%	—	$66.5M
CINGCingulate	$4.56	−3.39%	−14.4%	—	—	—	$66.3M	Compare
RANIRani Therapeutics Holdings	$0.5728	+3.06%	−40.3%	—	−432.7%	—	$66.1M	Compare
FBIOFortress Biotech	$1.97	+1.55%	−22.7%	+14.0%	−13.2%	0.6	$65.7M	Compare
TENXTenax Therapeutics	$1.81	−1.63%	−84.9%	—	—	—	$67.7M	Compare
TELOTelomir Pharmaceuticals	$0.8750	−3.85%	−34.7%	—	—	—	$64.5M	Compare
CRBPCorbus Pharmaceuticals Holdings	$3.57	−7.75%	−67.3%	—	—	—	$69.0M	Compare
MAIAMAIA Biotechnology	$1.14	+5.56%	−15.6%	—	—	—	$70.4M	Compare
PMVPPMV Pharmaceuticals	$1.33	−3.99%	−8.6%	—	—	—	$70.8M	Compare

News about Cumberland Pharmaceuticals

All news →

No recent articles focused on Cumberland Pharmaceuticals.

Quick answers

What does Cumberland Pharmaceuticals do?: Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products.
What is CPIX's market cap?: $66.52M, based on the Nov 4 close of $4.44.
Does Cumberland Pharmaceuticals pay a dividend?: Yes. The latest regular dividend was $1.5 per share (ex-date Aug 3), an annualised yield of 33.78%.
How much of CPIX is sold short?: 336.0K shares, 3.9% of float, as of Oct 15, 2026.
What sector is CPIX in?: Healthcare, in the Pharmaceuticals industry.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

HQ: Nashville,, TN93 employeesListed Aug 11, 2009cumberlandpharma.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology